Articles

Articles

Articles

The following information is intended for healthcare professionals only.

Below are links to published peer-reviewed articles featuring data from LumiThera-sponsored clinical trials, investigator-sponsored clinical trials, and photobiomodulation clinical trials.

The articles may contain information about treatments, populations, or uses that are not consistent with Valeda labeling or not approved by a regulatory authority. This is not a comprehensive or exhaustive list.

LumiThera does not suggest or recommend the use of its products in any manner other than as described in the Indications for Use in the Valeda User Manual.

Select a Category

By expanding you’re confirming that your query is unsolicited.

The indicated use is for treatment of ocular damage and disease using photobiomodulation, including inhibition of inflammatory mediators, edema or drusen deposition, improvement of wound healing following ocular trauma or surgery, and increase in visual acuity and contrast sensitivity in patients with degenerative diseases such as dry age-related macular degeneration.

Now’s the Time to Talk

Request time with one of our representatives to learn more about Valeda.

Contact Us
Valeda